Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus

For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity.

Related Keywords

Oklahoma , United States , Oklahoma City , Joant Merrill , , Oklahoma Medical Research Foundation , Bristol Myers Squibb , Healthday News , New England Journal , Systemic Lupus ,